Key facts
| Recalling firm | GE Healthcare Finland Oy |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | B105P, B125P, B105M, B125M, B155M Patient Monitors; Model nos. 6160000-002 6160000-003 6160000-004 6160000-005 6160000-101 6160000-102 6160000-103 6160000-104 6160000-105 6160001-063 6160001-064 6160001-065 Monitor, Physiological, Patient (With Arrhythmia Detection or Alarms 3/19/26 updated to add B105P Patient Monitor 6160001-061 B125P Patient Monitor 6160001-062 B105M-C Patient Monitor 6160002-033 B105M-A Patient Monitor 6160000-113 B155M-A Patient Monitor 6160000-115 B125P-B Patient Monitor 6160002-022 B105M-B Patient Monitor 6160002-023 B125M-B Patient Monitor 6160002-024 B105M-OR Patient Monitor 6160000-143 B105M-OR Patient Monitor 6160000-144 B155M-OR Patient Monitor 6160000-145 |
| Classification | Class II |
| Recall number | Z-0455-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Potential loss of monitoring on affected monitors when powered by certain batteries. Affected batteries can lose capability to hold charge and provide back up power. If this situation occurs, it will cause loss of patient monitoring and potentially delay recognizing patient status changes requiring treatment. |
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of B105P, B125P, B105M, B125M, B155M Patient Monitors; Model nos. 6160000-002 6160000-003 6160000-004 6160000-005 6160000-101 6160000-102 6160000-103 6160000-104 6160000-105 6160001-063 6160001-064 6160001-065 Monitor, Physiological, Patient (With Arrhythmia Detection or Alarms 3/19/26 updated to add B105P Patient Monitor 6160001-061 B125P Patient Monitor 6160001-062 B105M-C Patient Monitor 6160002-033 B105M-A Patient Monitor 6160000-113 B155M-A Patient Monitor 6160000-115 B125P-B Patient Monitor 6160002-022 B105M-B Patient Monitor 6160002-023 B125M-B Patient Monitor 6160002-024 B105M-OR Patient Monitor 6160000-143 B105M-OR Patient Monitor 6160000-144 B155M-OR Patient Monitor 6160000-145 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from GE Healthcare Finland Oy. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from GE Healthcare Finland Oy should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to GE Healthcare Finland Oy directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
GE Healthcare Finland Oy’s FDA history
Argus HQ has recorded 19 total FDA actions tied to GE Healthcare Finland Oy: 0 warning letters, 19 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Is B105P, B125P, B105M, B125M, B155M Patient Monitors; Model no recalled?
- Yes. FDA lists a Class II recall by GE Healthcare Finland Oy for B105P, B125P, B105M, B125M, B155M Patient Monitors; Model nos. 6160000-002 6160000-003 6160000-004 6160000-005 6160000-101 6160000-102 6160000-103 6160000-104 6160000-105 6160001-063 6160001-064 6160001-065 Monitor, Physiological, Patient (With Arrhythmia Detection or Alarms 3/19/26 updated to add B105P Patient Monitor 6160001-061 B125P Patient Monitor 6160001-062 B105M-C Patient Monitor 6160002-033 B105M-A Patient Monitor 6160000-113 B155M-A Patient Monitor 6160000-115 B125P-B Patient Monitor 6160002-022 B105M-B Patient Monitor 6160002-023 B125M-B Patient Monitor 6160002-024 B105M-OR Patient Monitor 6160000-143 B105M-OR Patient Monitor 6160000-144 B155M-OR Patient Monitor 6160000-145, reported 20251119, with status "Ongoing." FDA recall number: Z-0455-2026.
- What is the recall class for GE Healthcare Finland Oy's recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Why was B105P, B125P, B105M, B125M, B155M Patient Monitors; Model no recalled?
- FDA's recall record states the reason as: Potential loss of monitoring on affected monitors when powered by certain batteries. Affected batteries can lose capability to hold charge and provide back up power. If this situation occurs, it will cause loss of patient monitoring and potentially delay recognizing patient status changes requiring treatment.
- Who should I contact about this recall?
- Contact GE Healthcare Finland Oy directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for GE Healthcare Finland Oy- Recall: GE Healthcare Finland Oy — Class II recall: BATTERY FLEX-3S2P 10.8V 18650 LI-ION SMBUS used with affected patient monitors… →
- Recall: GE Healthcare Finland Oy — Class II recall: Portrait VSM Model nos. 6660000-666 Monitor, Physiological, Patient (With… →
- Recall: GE Healthcare Finland Oy — Class II recall: Carescape B450, Model no. 5805686 - shipped with potentially affected batteries… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE ONE, Model no. 2087075-300 - shipped with potentially affected batteri… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE Canvas Smart Display, Model Numbers: a) 5514418, b) 5514418 / MAE… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE Canvas 1000, Model Numbers: a) 5865770; b) 5865770-01040169; c) 58… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE B650: Model Numbers: a) MBB313, Model Numbers: 1) 2095801-001, 2… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023, b) 5700023-02, c)… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2025). Recall Record: Class II Recall: B105P, B125P, B105M, B125M, B155M Patient Monitors; Model… by GE Healthcare Finland Oy. Digital Empire LLC. Retrieved from https://argushq.ai/recall/ge-healthcare-finland-oy-z-0455-2026-2025-11-19
"Recall Record: Class II Recall: B105P, B125P, B105M, B125M, B155M Patient Monitors; Model… by GE Healthcare Finland Oy." Argus HQ Research, Digital Empire LLC, 2025, argushq.ai/recall/ge-healthcare-finland-oy-z-0455-2026-2025-11-19.
Argus HQ Research. "Recall Record: Class II Recall: B105P, B125P, B105M, B125M, B155M Patient Monitors; Model… by GE Healthcare Finland Oy." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/ge-healthcare-finland-oy-z-0455-2026-2025-11-19.
@misc{argushq_argushq_ai_recall_ge_healthcare_finland_oy_z_0455_2026_2025_11_19_2025,
title = {Recall Record: Class II Recall: B105P, B125P, B105M, B125M, B155M Patient Monitors; Model… by GE Healthcare Finland Oy},
author = {{Argus HQ Research}},
year = {2025},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/ge-healthcare-finland-oy-z-0455-2026-2025-11-19},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗

